HR 8630 119th Congress
To amend the Public Health Service Act to prohibit treatment of a biologic as a biological product based solely on the presence of a protein that is a clinically inactive component in such biologic, and for other purposes.
Latest Action
Referred to the House Committee on Energy and Commerce.
Sponsors
![Rep. Rulli, Michael A. [R-OH-6]](https://bioguide.congress.gov/bioguide/photo/R/R000619.jpg)
Actions
2026-04-30T00:00:00
Referred to the House Committee on Energy and Commerce.
2026-04-30T00:00:00
Introduced in House
2026-04-30T00:00:00
Introduced in House
Policy Areas
Health
Track this bill on CivicBeacon
Get push notifications when this bill is updated, contact your reps, and take action.
